´ç´¢º´ °ü¸® ºÐ¾ß ÀΰøÁö´É ½ÃÀå : À¯Çüº°, ¿ëµµº°, Àü°³º°, ÃÖÁ¾»ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2024-2032³â)
Artificial Intelligence in Diabetes Management Market, By Type, By Application, By Deployment, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
»óǰÄÚµå : 1605761
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2024³â 11¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 399 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,702,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,728,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 8,174,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

´ç´¢º´ °ü¸® ºÐ¾ß ÀΰøÁö´É ½ÃÀå ±Ô¸ð´Â 2023³â 212¾ï 3,400¸¸ ´Þ·¯·Î 2024³âºÎÅÍ 2032³â±îÁö 38.5%ÀÇ CAGR·Î È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

´ç´¢º´ °ü¸® ºÐ¾ß ÀΰøÁö´É ½ÃÀå - ½ÃÀå ¿ªÇÐ

´ç´¢º´ À¯º´·ü Áõ°¡¿Í AI ±â¼ú ¹ßÀüÀÌ ½ÃÀå ¼ö¿ä¸¦ ÃËÁø

¼¼°è ´ç´¢º´ ȯÀÚ Áõ°¡·Î ÀÎÇØ AI ±â¹Ý Áúº´ °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, 2021³â ±¹Á¦´ç´¢º´¿¬¸ÍÀº ¼ºÀÎ ´ç´¢º´ ȯÀÚ°¡ 5¾ï 3700¸¸ ¸í¿¡ ´ÞÇϰí 2045³â±îÁö 7¾ï 8300¸¸ ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±Þ°ÝÇÑ Áõ°¡·Î ÀÎÇØ AI¸¦ Ȱ¿ëÇÑ Ã·´Ü ´ç´¢º´ °ü¸® µµ±¸¿¡ ´ëÇÑ Çʿ伺ÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, AI¿Í ¸Ó½Å·¯´× ´É·ÂÀÇ Çâ»óÀ¸·Î ´ç´¢º´ °ü¸® ºÐ¾ßÀÇ AI ½ÃÀå ¼ºÀåÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ±×·¯³ª ÇコÄɾ AI ½Ã½ºÅÛÀ» µµÀÔÇÏ´Â µ¥¿¡´Â ¸¹Àº ºñ¿ëÀÌ ¼Ò¿äµÈ´Ù´Â Á¡ÀÌ °É¸²µ¹·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¹Ý¸é, ¼¼°è ÇコÄÉ¾î °³Çõ°ú Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê´Â AI ±â¹Ý ´ç´¢º´ °ü¸®¸¦ Áö¿øÇÏ¿© ½ÃÀå ±âȸ¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

´ç´¢º´ °ü¸® ºÐ¾ß ÀΰøÁö´É ½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®

´ç»çÀÇ ¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®°¡ °øÀ¯ÇÑ ºÐ¼®¿¡ µû¸£¸é, ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2024-2032³â) µ¿¾È ¾à 38.5%ÀÇ CAGR·Î ¸Å³â ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

À¯Çüº°·Î´Â Áø´ÜÀÌ 2023³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµÆ½À´Ï´Ù.

¿ëµµº°·Î´Â 2023³â Á¦2Çü ´ç´¢º´ÀÌ ÁÖ¿ä À¯ÇüÀ¸·Î ºÎ»óÇß½À´Ï´Ù.

2023³â¿¡´Â Ŭ¶ó¿ìµå ±â¹ÝÀÌ ÁÖ¿ä À¯ÇüÀ¸·Î ²ÅÇû½À´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2023³â ÁÖ¿ä ¼öÀÍ¿øÀ¸·Î ºÎ»óÇß½À´Ï´Ù.

´ç´¢º´ °ü¸® ºÐ¾ß ÀΰøÁö´É ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼®:

´ç´¢º´ °ü¸®ÀÇ ¼¼°è ÀΰøÁö´É ½ÃÀåÀº À¯Çü, ¿ëµµ, Àü°³, ÃÖÁ¾»ç¿ëÀÚ ¹× Áö¿ª¿¡ µû¶ó ¼¼ºÐÈ­µË´Ï´Ù.

À¯Çüº°·Î´Â Ä¡·á °èȹ, Áø´Ü, Áø´Ü, ȯÀÚ ÀÚ°¡ °ü¸®, Áø´Ü µî 4°¡Áö·Î ºÐ·ùµË´Ï´Ù. Áø´Ü ºÐ¾ß°¡ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀåÀº ´ç´¢º´ À¯º´·üÀÇ Áõ°¡¿Í Á¶±â ¹ß°ß¿¡ ´ëÇÑ Á߿伺ÀÌ ³ô¾ÆÁ³±â ¶§¹®ÀÔ´Ï´Ù.

ÀÌ ½ÃÀåÀº Àӽżº ´ç´¢º´, 1Çü ´ç´¢º´, Á¦2Çü ´ç´¢º´ÀÇ ¼¼ °¡Áö ¹üÁÖ·Î ³ª´µ¸ç, Á¦2Çü ´ç´¢º´ ºÎ¹®ÀÌ ½ÃÀåÀ» Áö¹èÇϰí ÀÖÀ¸¸ç, ¿¹Ãø ±â°£ µ¿¾È ±× ¿ìÀ§¸¦ À¯ÁöÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÀÌ´Â 1Çü ´ç´¢º´¿¡ ºñÇØ Á¦2Çü ´ç´¢º´ÀÇ À¯º´·üÀÌ Áõ°¡Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù.

´ç´¢º´ °ü¸® ºÐ¾ß ÀΰøÁö´É ½ÃÀå - Áö¸®Àû ÀλçÀÌÆ®

Áö¸®ÀûÀ¸·Î ÀÌ ½ÃÀåÀº ºÏ¹Ì, ¶óƾ¾Æ¸Þ¸®Ä«, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡ ºÐÆ÷µÇ¾î ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀº ºñÁî´Ï½º¸¦ °¡Á®¿À´Â ±¹°¡¿¡ µû¶ó ´õ ¼¼ºÐÈ­µË´Ï´Ù.

´ç´¢º´ °ü¸® ºÐ¾ß ÀΰøÁö´É ½ÃÀå - °æÀï »óȲ:

Á¤È®ÇÏ°í µ¥ÀÌÅÍ Áß½ÉÀÇ ´ç´¢º´ Ä¡·á¸¦ À§ÇÑ AI ±â¹Ý µµ±¸ÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¼¼°è ½ÃÀåÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀÇ ±â¾÷µéÀº ±âÁ¸ ´ç´¢º´ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ¿¡ AI¸¦ ÅëÇÕÇÏ¿© ½Ç½Ã°£ Ç÷´ç ºÐ¼® ¹× °³ÀÎÈ­µÈ ÃßõÀ» °¡´ÉÇÏ°Ô Çϱâ À§ÇØ ÀÇ·á ¼­ºñ½º Á¦°øÀÚ¿ÍÀÇ ÆÄÆ®³Ê½Ê¿¡ ÁýÁßÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±â¾÷µéÀº °í±Þ AI ¾Ë°í¸®Áò¿¡ ÅõÀÚÇÏ¿© ¿¹Ãø ´É·ÂÀ» Çâ»ó½Ã۰í Á¶±â °³ÀÔ°ú ÃÖÀûÈ­µÈ Ä¡·á ¿ä¹ýÀ» ÃËÁøÇÏ¿© ȯÀÚ °á°ú¸¦ °³¼±Çϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ´ç´¢º´ °ü¸® ºÐ¾ß ÀΰøÁö´É ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ´ç´¢º´ °ü¸® ºÐ¾ß ÀΰøÁö´ÉÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå ´ç´¢º´ °ü¸® ºÐ¾ß ÀΰøÁö´É »ê¾÷ ¿¬±¸

Á¦5Àå ´ç´¢º´ °ü¸® ºÐ¾ß ÀΰøÁö´É ½ÃÀå : ³ô¾ÆÁö´Â ÁöÁ¤ÇÐÀû ±äÀåÀÇ ¿µÇâ

Á¦6Àå ´ç´¢º´ °ü¸® ºÐ¾ß ÀΰøÁö´É ½ÃÀå »óȲ

Á¦7Àå ´ç´¢º´ °ü¸® ºÐ¾ß ÀΰøÁö´É ½ÃÀå - À¯Çüº°

Á¦8Àå ´ç´¢º´ °ü¸® ºÐ¾ß ÀΰøÁö´É ½ÃÀå - ¿ëµµº°

Á¦9Àå ´ç´¢º´ °ü¸® ºÐ¾ß ÀΰøÁö´É ½ÃÀå - Àü°³º°

Á¦10Àå ´ç´¢º´ °ü¸® ºÐ¾ß ÀΰøÁö´É ½ÃÀå - ÃÖÁ¾»ç¿ëÀÚº°

Á¦11Àå ´ç´¢º´ °ü¸® ºÐ¾ß ÀΰøÁö´É ½ÃÀå - Áö¿ªº°

Á¦12Àå ÁÖ¿ä º¥´õ ºÐ¼® - ´ç´¢º´ °ü¸® ºÐ¾ß ÀΰøÁö´É

Á¦13Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Artificial intelligence in diabetes management market size was valued at USD 21,234 Million in 2023, expanding at a CAGR of 38.5% from 2024 to 2032.

Artificial intelligence (AI) in diabetes management uses advanced algorithms and data-driven insights to monitor, predict, and optimize patient care. By analyzing blood glucose patterns, diet, exercise, and lifestyle data, AI systems offer personalized recommendations for medication dosing, dietary adjustments, and activity levels. This technology improves real-time decision-making, enhances glycemic control, and helps healthcare providers deliver proactive, efficient, and patient-specific diabetes management, ultimately reducing complications and promoting healthier outcomes.

Artificial Intelligence in Diabetes Management Market- Market Dynamics

Increasing prevalence of diabetes and technological advancements in AI to propel market demand

The global increase in diabetes cases fuels demand for AI-driven solutions in disease management. In 2021, the International Diabetes Federation reported 537 million adults with diabetes, a figure expected to reach 783 million by 2045. This surge amplifies the need for advanced, AI-enabled diabetes management tools. Besides, improved AI and machine learning capabilities drive the growth of AI in diabetes management market. However, the significant costs of deploying AI systems in healthcare act as a barrier. On the contrary, the global healthcare reforms and government initiatives are supporting AI-driven diabetes care, thereby boosting opportunities for the market.

Artificial Intelligence in Diabetes Management Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 38.5% over the forecast period (2024-2032)

Based on type segmentation, diagnostics was predicted to show maximum market share in the year 2023

Based on application segmentation, type 2 diabetes was the leading type in 2023

Based on deployment segmentation, cloud-based was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Artificial Intelligence in Diabetes Management Market- Segmentation Analysis:

The Global Artificial Intelligence in Diabetes Management Market is segmented on the basis of Type, Application, Deployment, End User, and Region.

The market is divided into four categories based on type: treatment planning, diagnostics, patient self-management, and diagnostics. The diagnostics sector dominates the market. This growth can be attributed to the the rising prevalence of diabetes and the growing emphasis on early detection.

The market is divided into three categories based on application: gestational diabetes, type 1 diabetes, and type 2 diabetes. The type 2 diabetes sector dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to an increasing prevalence of type 2 diabetes compared to type 1 diabetes.

Artificial Intelligence in Diabetes Management Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Artificial Intelligence in Diabetes Management Market- Competitive Landscape:

The global market is expanding due to increased adoption of AI-driven tools for precise, data-oriented diabetes care. Companies in this market are focusing on partnerships with healthcare providers to integrate AI into existing diabetes monitoring systems, enabling real-time blood glucose analysis and personalized recommendations. Additionally, firms are investing in advanced AI algorithms to enhance predictive capabilities, facilitating early intervention and optimized treatment regimens to improve patient outcomes.

Recent Developments:

In March 2024, Roche introduced the AI-powered diabetes tracker, Accu-Chek SmartGuide, which uses real-time continuous glucose monitoring to predict blood sugar fluctuations up to two hours ahead.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET, BY DEPLOYMENT- MARKET ANALYSIS, 2019 - 2032

GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1. Artificial Intelligence in Diabetes Management Market Overview

2. Executive Summary

3. Artificial Intelligence in Diabetes Management Key Market Trends

4. Artificial Intelligence in Diabetes Management Industry Study

5. Artificial Intelligence in Diabetes Management Market: Impact of Escalating Geopolitical Tensions

6. Artificial Intelligence in Diabetes Management Market Landscape

7. Artificial Intelligence in Diabetes Management Market - By Type

8. Artificial Intelligence in Diabetes Management Market - By Application

9. Artificial Intelligence in Diabetes Management Market - By Deployment

10. Artificial Intelligence in Diabetes Management Market - By End User

11. Artificial Intelligence in Diabetes Management Market- By Geography

12. Key Vendor Analysis- Artificial Intelligence in Diabetes Management Industry

13. 360 Degree Analyst View

14. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â